VectivBio reels in $110m
VectivBio AG, a Swiss developer of transformational medicines for patients with serious rare diseases, has raised $110 million in financing.
VectivBio AG, a Swiss developer of transformational medicines for patients with serious rare diseases, has raised $110 million in financing.
Copyright PEI Media
Not for publication, email or dissemination